Stock Traders Buy High Volume of Call Options on Teladoc Health (NYSE:TDOC)

Teladoc Health, Inc. (NYSE:TDOC) was the target of some unusual options trading on Friday. Stock traders acquired 18,240 call options on the stock. This represents an increase of approximately 53% compared to the average volume of 11,885 call options.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on TDOC shares. Deutsche Bank Aktiengesellschaft upgraded shares of Teladoc Health from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a research report on Tuesday, March 10th. Citigroup upped their price objective on shares of Teladoc Health from $6.00 to $7.00 and gave the company a “neutral” rating in a research note on Tuesday, May 5th. JPMorgan Chase & Co. cut their price objective on shares of Teladoc Health from $9.00 to $7.00 and set a “neutral” rating for the company in a report on Friday, March 13th. Barclays cut their price objective on shares of Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a report on Thursday, March 26th. Finally, Oppenheimer lowered their target price on Teladoc Health from $12.00 to $7.00 and set an “outperform” rating on the stock in a report on Tuesday, March 3rd. Five investment analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $7.43.

Teladoc Health Stock Up 5.7%

Shares of TDOC opened at $8.36 on Friday. The company’s 50-day moving average price is $6.89 and its 200 day moving average price is $6.25. Teladoc Health has a 12-month low of $4.40 and a 12-month high of $9.77. The company has a current ratio of 2.80, a quick ratio of 2.72 and a debt-to-equity ratio of 0.75. The firm has a market cap of $1.51 billion, a P/E ratio of -8.62 and a beta of 2.14.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Wednesday, April 29th. The health services provider reported ($0.36) earnings per share for the quarter, missing the consensus estimate of ($0.35) by ($0.01). Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The company had revenue of $613.85 million for the quarter, compared to analysts’ expectations of $611.04 million. During the same period last year, the business earned ($0.53) EPS. The company’s quarterly revenue was down 2.5% compared to the same quarter last year. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. On average, sell-side analysts forecast that Teladoc Health will post -0.92 earnings per share for the current year.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 7,906 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $60,322.78. Following the transaction, the insider owned 110,261 shares in the company, valued at approximately $841,291.43. This trade represents a 6.69% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of Teladoc Health stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $47,275.48. Following the sale, the insider directly owned 57,671 shares in the company, valued at approximately $440,029.73. This trade represents a 9.70% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders sold 39,870 shares of company stock valued at $302,507. Insiders own 0.70% of the company’s stock.

Institutional Trading of Teladoc Health

Several institutional investors have recently added to or reduced their stakes in TDOC. IFP Advisors Inc lifted its stake in Teladoc Health by 412.1% during the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock worth $31,000 after purchasing an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. boosted its position in shares of Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after buying an additional 2,810 shares during the period. Aster Capital Management DIFC Ltd grew its stake in shares of Teladoc Health by 101.1% in the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,425 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in shares of Teladoc Health by 694.5% in the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock valued at $31,000 after buying an additional 4,945 shares in the last quarter. Finally, International Assets Investment Management LLC purchased a new stake in shares of Teladoc Health in the 4th quarter valued at $45,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.